Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

about

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

Item

http://www.wikidata.org/entity/Q52648932

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@en

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@nl

type

Item

label

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@en

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@nl

prefLabel

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@en

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@nl

P1476

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.

@en

P2093

Jiajun Dong

http://www.w3.org/2001/XMLSchema#string

Jincheng Yang

http://www.w3.org/2001/XMLSchema#string

Qiming Kan

http://www.w3.org/2001/XMLSchema#string

Qingzhi Lv

http://www.w3.org/2001/XMLSchema#string

Ruoshi Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Wei

http://www.w3.org/2001/XMLSchema#string

Youjun Xu

http://www.w3.org/2001/XMLSchema#string

Zhengtao Yang

http://www.w3.org/2001/XMLSchema#string

Zhonggui He

http://www.w3.org/2001/XMLSchema#string

P2860

Microtubules as a target for anticancer drugs

Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.

Impact of albumin on drug delivery--new applications on the horizon.

Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.

Natural products as leads to anticancer drugs.

Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines

Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.

Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles.

Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy

P304

807-814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10717544.2018.1451935

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29553858

http://www.w3.org/2001/XMLSchema#string

P932

6058529

http://www.w3.org/2001/XMLSchema#string